SMEs (small and medium-sized enterprises) see benefit from UK Patents Bill:
This article was originally published in Clinica
The UK Patents Bill was passed by parliament on July 14, at the third reading. It incorporates a clause (amending section 106 of the Patents Act 1977) that aims to "make a small additional improvement to the framework for enforcement of patent rights" and an amendment which seek to address the concerns particularly of small and medium-sized enterprises (SMEs). The changes "aim to help SMEs in appropriate circumstances where they face litigation in the courts", taking into account the need for the framework to be "accessible to an SME patent holder, but which is also fair to a party against whom enforcement action may be taken, [which] may be another SME".
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.